Evaluating single point measurement for dosimetry in 177Lu-DOTATATE therapy

被引：0
|
作者：
Svensson, J. [1 ]
Hermann, R. [2 ]
Ryden, T. [2 ]
Hagmarker, L. [2 ]
Bernhardt, P. [2 ]
机构：
[1] Inst Clin Sci, Dept Oncol, Gothenburg, Sweden
[2] Inst Clin Sci, Dept Radiat Phys, Gothenburg, Sweden
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2018年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0725
引用
收藏
页码：S590 / S590
页数：1
相关论文
共 50 条
  • [1] Single time point tumour dosimetry after 177Lu-DOTATATE therapy
    Ballout, S.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S746 - S746
  • [2] Single time point uptake value as a surrogate marker for 177Lu-DOTATATE dosimetry
    Miederer, Matthias
    Reber, Helmut
    Helisch, Andreas
    Fottner, Christian
    Weber, Matthias
    Schreckenberger, Mathias
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [3] Feasibility and accuracy of single time point imaging for renal dosimetry following 177Lu-DOTATATE ("Lutate') therapy
    Willowson, Kathy P.
    Eslick, Enid
    Ryu, Hyunju
    Poon, Aurora
    Bernard, Elizabeth J.
    Bailey, Dale L.
    [J]. EJNMMI PHYSICS, 2018, 5
  • [4] Feasibility and accuracy of single time point imaging for renal dosimetry following 177Lu-DOTATATE (‘Lutate’) therapy
    Kathy P. Willowson
    Enid Eslick
    Hyunju Ryu
    Aurora Poon
    Elizabeth J. Bernard
    Dale L. Bailey
    [J]. EJNMMI Physics, 5
  • [5] 177Lu-DOTATATE Quantification for Patient Personalised Dosimetry in Therapy of Neuroendocrine Tumours
    Rodrigues, C.
    Ferreira, P.
    Oliveira, F. P. M.
    Silva, A.
    Peralta, L.
    Costa, D. C.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S656 - S656
  • [6] An image based method for bone marrow dosimetry in 177Lu-DOTATATE therapy
    Svensson, J.
    Soderstrom, J.
    Magnander, T.
    Wikberg, E.
    Wangberg, B.
    Bernhardt, P.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S9 - S9
  • [7] Dosimetry in patients undergoing 177Lu-DOTATATE therapy with indications for 90Y-DOTATATE
    Cremonesi, M.
    Ferrari, M. E.
    Bodei, L.
    Bartolomei, M.
    Chinol, M.
    Mei, R.
    Daou, B.
    Tosi, G.
    Paganelli, G.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S102 - S102
  • [8] 177LU-DOTATATE THERAPY IN PROGRESSIVE MENINGIOMA
    Muether, M.
    Roll, W.
    Zinnhardt, B.
    Schaefers, M.
    Rahbar, K.
    Brokinkel, B.
    Stummer, W.
    [J]. NEURO-ONCOLOGY, 2019, 21 : 39 - 39
  • [9] Neuroendocrine Tumor Therapy: 177Lu-DOTATATE
    Mittra, Erik S.
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2018, 211 (02) : 278 - 285
  • [10] 177Lu-DOTATATE therapy in progressive meningioma
    Roll, W.
    Muether, M.
    Zinnhardt, B.
    Stegger, L.
    Schaefers, M.
    Weckesser, M.
    Stummer, W.
    Rahbar, K.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S644 - S644
12345